Wegovy works well for most people who take it. In the longest clinical trial to date, patients lost an average of 15.2% of their body weight over two years, compared to just 2.6% for those taking a placebo. That’s a meaningful difference, and for someone weighing 250 pounds, it translates to roughly 30 to 35 pounds beyond what diet and exercise alone would achieve.
How Much Weight People Actually Lose
The clearest picture comes from the STEP 5 trial, which followed 304 adults with obesity or overweight for two full years. Everyone in the study followed a reduced-calorie meal plan and increased their physical activity. The group taking Wegovy lost 15.2% of their starting body weight on average, while the placebo group lost 2.6%. That net difference of about 12.6 percentage points held up with strong statistical significance.
Shorter trials have shown similar patterns. In a 68-week study of nearly 2,000 adults, participants on Wegovy consistently outperformed those on placebo by wide margins. These aren’t cherry-picked results from the best responders. They’re averages across diverse groups of people, which means some lost considerably more and others less.
When You’ll Start Seeing Results
Wegovy begins affecting your appetite within days of your first injection, but visible weight loss takes longer. The medication uses a gradual dose schedule that ramps up over about four months, partly to let your body adjust and partly to reduce side effects. Here’s what the timeline looks like on average:
- Weeks 1 to 4 (lowest dose): About 2% of starting body weight lost
- Weeks 5 to 8: Around 4% total loss
- Weeks 9 to 12: Around 6% total loss
- Weeks 13 to 16: Around 8% total loss
The steepest weight loss happens after you reach the full maintenance dose, typically around week 17. Most people continue losing weight for months beyond that point, with results accumulating through the first year and into the second. The trajectory isn’t linear. Early weeks may feel slow because you’re on lower doses, and the pace eventually plateaus as your body reaches a new equilibrium.
How Wegovy Works in Your Body
Wegovy contains semaglutide, which mimics a hormone your gut naturally releases after eating called GLP-1. This hormone does several things at once: it signals your brain to feel full, slows the rate at which food leaves your stomach, and triggers the release of other satiety hormones like leptin and peptide YY. The net effect is that you feel satisfied with less food and think about eating less often.
What makes semaglutide particularly effective is that it lasts much longer in your body than the natural hormone does. Natural GLP-1 breaks down within minutes. Semaglutide sticks around for about a week, which is why you only inject it once. It also crosses into the brain, where it acts on appetite-control centers in the hypothalamus and other regions. This central effect on the brain is a big part of why people report that their “food noise,” the constant mental chatter about what to eat next, quiets down significantly.
Benefits Beyond Weight Loss
The SELECT trial, one of the largest cardiovascular outcome studies ever conducted with a weight-loss medication, found that Wegovy reduced the risk of heart attack, stroke, and cardiovascular death by 20% over roughly 33 months. This was in people who already had heart disease but did not have diabetes. That finding led the FDA to approve Wegovy specifically for reducing cardiovascular risk in this population, making it the first weight-management drug to earn that distinction.
How It Compares to Zepbound
Zepbound (tirzepatide) is the main competitor, and studies suggest it produces somewhat greater weight loss than Wegovy on average. Zepbound works on two gut hormone pathways instead of one, which likely explains the difference. That said, both medications produce clinically significant results, and “more weight loss” isn’t always the right goal. Individual responses vary, and factors like side effect tolerance, cost, insurance coverage, and availability all play into which medication works better for a given person.
Side Effects During Treatment
Gastrointestinal symptoms are the most common downside. In clinical trials, about 44% of people on Wegovy experienced nausea, 30% had diarrhea, and 24% had vomiting. These numbers sound high, but context matters. Most GI side effects are worst during the dose-escalation phase and improve as your body adjusts. The gradual titration schedule, starting at a quarter of the final dose and stepping up every four weeks, exists specifically to make this transition more manageable.
If side effects remain problematic even at the full dose, the maintenance dose can be lowered from 2.4 mg to 1.7 mg weekly. This still produces meaningful weight loss for most people, though somewhat less on average than the higher dose.
Who Can Get a Prescription
The FDA approves Wegovy for adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) if they also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol. It’s also approved for adolescents aged 12 and older whose BMI is at or above the 95th percentile for their age and sex. In all cases, it’s meant to be used alongside dietary changes and increased physical activity, not as a standalone fix.
What Happens if You Stop Taking It
This is one of the most important things to understand about Wegovy. The medication works by changing your hormonal signaling, not by permanently resetting your metabolism. When people stop taking it, appetite typically returns to baseline and weight regain is common. Clinical data consistently show that most of the lost weight comes back within a year or two of discontinuation. For many people, Wegovy is an ongoing treatment rather than a temporary course, similar to how blood pressure medication manages but doesn’t cure hypertension.